HG-1296

N/A

Report date: 2025/02/01 20:00:06

NME

Base Information

Drug NameHG-1296

Drug Alias NameFKSG40 gene product modulator (Human Genome Sciences)IGFBPRP10 modulator (Human Genome Sciences)KAZALD1 modulator (Human Genome Sciences)bone- and odontoblast-expressed gene 1 modulator (Human Genome Sciences)kazal-type protease inhibitor domain-containing protein 1 modulator (Human Genome Sciences) +[10]

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionKazal type serine peptidase inhibitors modulators

TargetsKazal type serine peptidase inhibitors

Therapy Area/IndicationsImmune System DiseasesCardiovascular DiseasesNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesHuman Genome Sciences Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesHuman Genome Sciences Inc

Active IndicationsN/A

Inactive IndicationsImmune System DiseasesCardiovascular DiseasesNeoplasms

Other Information

ATC CodeN/A